Screening for group B Streptococcal infection in late pregnant women in Xuzhou area and its drug sensitivity analysis
10.3969/j.issn.1673-4130.2015.20.017
- VernacularTitle:徐州地区妊娠晚期妇女感染B群链球菌的筛检情况及药物敏感性分析
- Author:
Jing WANG
;
Jie LIU
;
Shuzhen WANG
;
Ping MA
- Publication Type:Journal Article
- Keywords:
late pregnancy;
group B streptococcus;
fluorescence PCR technology;
resistance
- From:
International Journal of Laboratory Medicine
2015;(20):2963-2964,2966
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the colonization rates of group B streptococcus (GBS) detected by using fluorescent PCR and bacterial culture in late pregnant women in Xuzhou area and analyze the drug resistance of GBS .Methods The fluorescence PCR assay and bacterial culture assay for GBS were both performed for the late‐pregnant women′s vaginal swabs and anal swabs samples which were collected in this area .The diagnostic efficiency were compared between the two methods .Then the drug sensitivity test were performed for stains isolated for the bacteria culture .Results Among the 484 spcimens ,53 cases were positive detected by u‐sing fluorescent PCR ,and the positive rate was 11 .0% ,the sensitivity was 100 .0% .31 cases were detected positive by using bacte‐rial culture ,and the positive rate was 6 .4% ,the sensitivity was 59 .6% .There were statistically significant differences between the positive rate and the sensitivity of the two groups(P<0 .05) .The drug sensitivity test showed that the sensitive rates were 100 .0%to penicillin ,ceftriaxone ,vancomycin .The resistance rates to erythromycin ,clindamycin ,levofloxacin were 71 .0% ,64 .5% and 58 .1% ,respectively .Conclusion The screening rate of GBS in late pregnant women is not low in Xuzhou area .PCR is a more rap‐id ,specificific and sensitive method .Routine detection of GBS should carried out by using the method of fluorescent PCR .Resistance rate of GBS to erythromycin and clindamycin were high in Xuzhou area .More attention should be paid to the rational use of antibi‐otics to prevent drug‐resistant producing in strains of GBS .
